Overview of Key Overnight Developments on May 21
21:00-7:00 Keywords: Gold, Blackstone, Uniswap, Texas
1. Michael Saylor: Bitcoin is transforming the equity capital markets;
2. Bitcoin open interest reaches an all-time high of $72 billion;
3. Blackstone makes its first bet on Bitcoin, purchasing only $1.08 million in IBIT funds;
4. Bancor sues Uniswap for infringing on its DEX smart contract technology patent;
5. Gold returns to $3,300, reportedly as Israel prepares to strike Iranian nuclear facilities;
6. Texas passes Bitcoin reserve investment bill, awaiting governor's approval to take effect;
7. US SEC Chairman: Promoting transparency and accountability in SEC's crypto regulation;
8. US SEC delays decision on XRP and Dogecoin ETF proposals, seeking public comment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cross-chain atomic transactions between Ethereum mainnet and L2

US Stock Movement | US clinical-stage biopharmaceutical company Retension Pharmaceuticals (RTSN.US) enters the US stock market, shares drop over 10% after opening
According to Jinse Finance, Retension Pharmaceuticals (RTSN.US) debuted on the US stock market on Friday and fell over 10% to $10.77 at press time, with an IPO price of $12. Retension Pharmaceuticals is a US-based clinical-stage biopharmaceutical company focused on developing innovative drugs for the treatment of hypertension and other cardiovascular diseases. The company's core investigational drug, RTN-001, is a new generation phosphodiesterase 5 (PDE5) inhibitor, primarily targeting patients with uncontrolled or resistant hypertension, and is currently undergoing a Phase IIb clinical trial. This drug works by enhancing nitric oxide signaling in blood vessels to promote vasodilation and lower blood pressure. The exclusive global development license comes from French pharmaceutical giant Sanofi (SNY.US).
Chevron has suspended production operations at five facilities in the U.S. Gulf region.
Chevron (CVX.US) has evacuated personnel and shut down production operations at five facilities in the US Gulf region, while another four offshore platforms continue production.
